In human postmortem studies, scientists showed a decreased ERK1/2 activity and expression in the prefrontal cortex and hippocampus, two major brain structures affected by depression (Dwivedi et al. 2001; Liu et al. 2017). The gene discussed is MAPK3; the disease is depressive disorder.